DMTRF
Price:
$1.91
Market Cap:
$36.71B
3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.
Industry
Medical - Devices
IPO Date
2013-06-19
Stock Exchange
OTC
Ticker
DMTRF
According to 3-D Matrix, Ltd.’s latest financial reports and current stock price. The company's current ROE is -129.53%. This represents a change of 250.74% compared to the average of -36.93% of the last 4 quarters.
The mean historical ROE of 3-D Matrix, Ltd. over the last ten years is -192.66%. The current -129.53% ROE has changed -32.77% with respect to the historical average. Over the past ten years (40 quarters), DMTRF's ROE was at its highest in in the April 2024 quarter at 125.80%. The ROE was at its lowest in in the April 2020 quarter at -202.43%.
Average
-192.66%
Median
-117.06%
Minimum
-654.56%
Maximum
-53.41%
Discovering the peaks and valleys of 3-D Matrix, Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 287.68%
Maximum Annual ROE = -53.41%
Minimum Annual Increase = -84.48%
Minimum Annual ROE = -654.56%
| Year | ROE | Change |
|---|---|---|
| 2025 | -112.86% | 56.06% |
| 2024 | -72.32% | -84.48% |
| 2023 | -466.10% | 258.59% |
| 2022 | -129.98% | 7.20% |
| 2021 | -121.25% | -81.48% |
| 2020 | -654.56% | 287.68% |
| 2019 | -168.84% | 99.21% |
| 2018 | -84.76% | 58.69% |
| 2017 | -53.41% | -14.53% |
| 2016 | -62.49% | 99.89% |
The current ROE of 3-D Matrix, Ltd. (DMTRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-217.09%
5-year avg
-180.50%
10-year avg
-192.66%
3-D Matrix, Ltd.’s ROE is less than American Oncology Network, Inc. (235.23%), greater than Oneview Healthcare PLC (-127.50%), greater than Alterola Biotech, Inc. (-14.67%), greater than Euroapi S.A. (-12.83%), less than Spectral Medical Inc. (62.09%), less than Hansa Biopharma AB (publ) (115.70%), greater than Transgene S.A. (-634.16%), less than Integrated Diagnostics Holdings plc (37.65%), greater than Cellectis S.A. (-49.81%), greater than Mayne Pharma Group Limited (-22.99%),
| Company | ROE | Market cap |
|---|---|---|
| 235.23% | $325.24M | |
| -127.50% | $119.14M | |
| -14.67% | $291.90K | |
| -12.83% | $341.82M | |
| 62.09% | $265.72M | |
| 115.70% | $246.65M | |
| -634.16% | $132.89M | |
| 37.65% | $405.94M | |
| -49.81% | $325.46M | |
| -22.99% | $191.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 3-D Matrix, Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 3-D Matrix, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is 3-D Matrix, Ltd.'s ROE?
How is the ROE calculated for 3-D Matrix, Ltd. (DMTRF)?
What is the highest ROE for 3-D Matrix, Ltd. (DMTRF)?
What is the 3-year average ROE for 3-D Matrix, Ltd. (DMTRF)?
What is the 5-year average ROE for 3-D Matrix, Ltd. (DMTRF)?
How does the current ROE for 3-D Matrix, Ltd. (DMTRF) compare to its historical average?